In this article, well explore the potential of GLP-1 patches, how they might fit into the broader treatment landscape, and what patients considering metabolic health support should know about the future of these therapies
Nausea hits 28% of users, vomiting 17%, diarrhea 24%, and constipation 21%
Can I take semaglutide every other week instead of weekly
Missing a dose carries the risk of lost therapeutic benefit, potential dose reset, and the frustration of losing momentum
Some industry stakeholders are concerned that ePA could be perceived as removing necessary speed bumps in high-cost drug use
With these official approvals and guideline recommendations, pharmaceutical companies are now able to conduct legitimate direct-to-consumer (DTC) education and outreach campaigns, accelerating the expansion of public awareness, acceptance and adoption of GLP-1 treatments in China